Shionogi's COVID-19 vaccine matches Pfizer's Comirnaty in booster trial

Shionogi’s COVID-19 vaccine candidate has held its own against Pfizer’s Comirnaty in a study of the effect of booster shots on antibody levels, offering the company encouragement as it barrels toward a filing for approval of S-268019 in Japan.